Much more information from Shelly:
Influenza
updates
from the
AVMA
Backgrounder:
Canine
influenza
September
7, 2009
Printer-friendly
version
(PDF)
Causative
agent
Canine
influenza
virus (CIV)
is
caused
by a
highly
contagious
infection
caused
by a
novel
influenza
A
subtype
H3N8
virus
first
discovered
in 2004.
The
canine
influenza
virus
has been
classified
as H3N8,
based on
the
amino
acid
composition
of the
hemaglutinin
(H) and
neuraminidase
(N)
glycoproteins
in the
lipid
outer
layer of
the
capsid.
These
glycoproteins
facilitate
entry
into and
release
from
host
cells,
and are
important
targets
for
antibodies
against
the
virus
(generated
as a
result
of
infection
or
response
to
vaccination).
The
viruses
are
80-120
nanometers
(nm) in
diameter,
and
consist
of a
core of
eight
separate
pieces
of
single-strand
ribonucleic
acid
(RNA)
surrounded
by a
spiked
arrangement
of
glycoproteins.
CIV
represents
a very
rare
event in
adaptive
evolution;
the
entire
genome
of the
H3N8
equine
influenza
virus
was
transferred
to dogs,
and the
virus
adapted
to the
canine
species
to
emerge
as a new
canine-specific
virus.1
Although
the
virus
spreads
readily
from dog
to dog,
there is
no
evidence
to
support
that it
can be
transmitted
from
dogs to
humans.
Natural
distribution
The
first
recognized
outbreak
of
canine
influenza
is
believed
to have
occurred
in
racing
greyhounds
in
January
2004 at
a track
in
Florida.
From
June to
August
of 2004,
outbreaks
of
respiratory
disease
were
reported
at 14
tracks
in 6
states
(Florida,
Texas,
Alabama,
Arkansas,
West
Virginia,
and
Kansas).
Between
January
and May
of 2005,
outbreaks
occurred
at 20
tracks
in 11
states
(Florida,
Texas,
Arkansas,
Arizona,
West
Virginia,
Kansas,
Iowa,
Colorado,
Rhode
Island,
and
Massachusetts).
Since
then,
canine
influenza
has been
documented
in 30
states
and
Washington,
DC. At
this
time,
CIV is
endemic
(very
prevalent)
in areas
of in
Colorado,
Florida,
New
York,
and
Pennsylvania.2
As of
October
2, 2008,
1,079
cases of
canine
influenza
were
confirmed
by the
Cornell
University
College
of
Veterinary
Medicine
Animal
Health
Diagnostic
Center.3
Transmission
Canine
influenza
is
spread
via
aerosolized
respiratory
secretions
and
contaminated
objects
(kennel
surfaces,
food and
water
bowls,
collars
and
leashes)
and
people
moving
between
infected
and
uninfected
dogs.
The
virus
can
remain
viable
(alive
and able
to
infect)
on
surfaces
for up
to 48
hours,
on
clothing
for 24
hours,
and on
hands
for 12
hours.4
The
incubation
period
is
usually
two to
four
days
from
exposure
to onset
of
clinical
signs.
The
highest
amounts
of viral
shedding
occur
during
this
time;
therefore,
dogs are
most
contagious
during
this 2-4
day
incubation
period
when
they are
not
exhibiting
signs of
illness.
4 Virus
shedding
decreases
dramatically
during
the
first 4
days of
illness
but may
continue
up to 7
days in
most
dogs and
up to 10
days in
some
dogs.4
Because
this is
a newly
emerging
pathogen,
all
dogs,
regardless
of breed
or age,
are
susceptible
to
infection
and have
no
naturally
acquired
or
vaccine-induced
immunity
when
first
exposed
to the
virus.
If the
virus
enters a
kennel
or other
closed
group, a
high
percentage
of the
dogs may
become
infected,
and most
of these
dogs
will be
symptomatic.2
Approximately
20-25%
of
infected
dogs are
expected
to
remain
asymptomatic,
but can
still
shed the
virus
and
spread
the
virus.
Although
most
dogs
have a
milder
form of
canine
influenza
and
recover
without
complications,
some may
develop
severe
pneumonia.1
Pathology
and
Clinical
Signs
The
canine
influenza
virus
infects
and
replicates
inside
the
cells of
the
respiratory
tract,
from the
nasal
lining
to the
terminal
airways.
The
inflammatory
response
results
in
rhinitis,
tracheitits,
bronchitis
and
bronchiolitis.
The
pathologic
process
also
involves
the
death of
the
epithelial
cells
lining
the
respiratory
tract,
resulting
in
exposure
of the
underlying
basement
membrane.
This, in
turn,
predisposes
the
respiratory
tract to
secondary
bacterial
infections
that
contribute
to the
nasal
discharge
and
coughing.4
Virtually
all dogs
that are
exposed
become
infected
with the
virus,
but
approximately
80%
develop
clinical
signs of
disease.
The
approximately
20% of
infected
dogs
that do
not
exhibit
clinical
signs of
disease
can
still
shed the
virus
and can
spread
the
infection.5
Like
other
mammalian
influenza
viruses,
CIV
causes
an acute
respiratory
infection
in dogs.
However,
unlike
human
influenza,
CIV is
not a
"seasonal"
flu –
infections
can
occur
year-round.2,4
Canine
influenza
virus
causes
clinical
disease
that
mimics
kennel
cough.
As a
result,
infection
with the
virus is
frequently
mistaken
for
infections
caused
by
Bordetella
bronchiseptica/parainfluenza
virus
complex.
Clinical
disease
may be
mild or
severe.6
The
majority
of
infected
dogs
exhibit
the mild
form of
CI. In
the mild
form,
the most
common
clinical
sign is
a cough
that
persists
for 10
to 21
days
despite
treatment
with
antibiotics
and
cough
suppressants.
Most
dogs
have a
soft,
moist
cough,
whereas
others
have a
dry
cough
that is
similar
to that
induced
by
Bordetella
bronchiseptica/parainfluenza
virus
infection.
Many
dogs
have a
purulent
nasal
discharge
and a
low-grade
fever.
The
nasal
discharge
is
usually
caused
by
secondary
bacterial
infections,
including
Pasteurella
multocida
and
mycoplasma
species.7
Some
dogs are
more
severely
affected
with
clinical
signs of
pneumonia,
such as
a
high-grade
fever
(104°F
to
106°F)
and
increased
respiratory
rate and
effort.
Thoracic
radiography
(chest
x-rays)
may
reveal
consolidation
of lung
lobes.1
Diagnosis
Canine
influenza
cannot
be
diagnosed
solely
by
clinical
signs
because
the
clinical
signs
(coughing,
sneezing
and
nasal
discharge)
are
similar
to those
associated
with all
of the
other
respiratory
pathogens
and
cannot
be
differentiated
from
them.4.
Antibodies
to
canine
influenza
virus
may be
detected
in the
blood as
early as
seven
days
after
onset of
clinical
signs,
and the
virus
may be
identified
in nasal
or
pharyngeal
swabs
during
the
first 4
days of
illness.
The most
reliable
and
sensitive
method
for
confirmation
of
infection
is
serologic
testing.
Paired
acute
serum
samples
(taken
within
the
first 7
days of
illness)
and
convalescent
serum
samples
(taken
10-14
days
later)
are
necessary
for
diagnosis
of
recent
infection.
If an
acute
sample
is not
available,
a
convalescent
sample
will
indicate
whether
a dog
has been
exposed
to the
virus at
some
point in
the
past. A
diagnosis
of CI is
made
based on
a
four-fold
increase
in
antibody
titer
from the
acute to
the
convalescent
sample.7
If a dog
has been
ill for
less
than 4
days,
nasal
and
pharyngeal
swab
submission
for
Polymerase
Chain
Reaction
(PCR)
testing
can be
performed.
If the
PCR
indicates
a
positive
result,
the dog
is most
likely
infected.
Negative
PCR
results
may be
falsely
negative
if the
swabs
are not
collected
during
the time
of peak
virus
shedding.
After 4
days of
illness,
PCR
results
are less
likely
to be
reliable.4,8
Serology
should
be
performed
to
confirm
infection,
especially
if the
PCR
results
are
negative
and the
case is
highly
suspicious
for CI
infection.4
Other
diagnostic
options
applicable
to dogs
that
have
died
from
pneumonia
are
viral
culture
and PCR
analysis
using
fresh
(not
formalin-preserved
or
frozen)
lung and
tracheal
tissues.
Virus
detection
in
respiratory
secretion
specimens
from
acutely
ill
animals
by use
of viral
culture,
PCR
analysis,
or rapid
chromatographic
immunoassay
is
possible,
but
usually
unrewarding.
The
Cornell
Animal
Health
Diagnostic
Center
is
currently
accepting
samples
for
analysis.
Treatment
As for
all
viral
diseases,
treatment
is
largely
supportive.
Good
husbandry
and
nutrition
may
assist
dogs in
mounting
an
effective
immune
response.
In the
milder
form of
the
disease,
a thick
green
nasal
discharge
most
likely
represents
a
secondary
bacterial
infection
that
usually
resolves
quickly
after
treatment
with a
broad-spectrum
bactericidal
antimicrobial.
Pneumonia
in more
severely
affected
dogs
responds
best to
a
combination
of
broad-spectrum
bactericidal
antimicrobials
(to
combat
secondary
bacterial
infections)
and
maintenance
of
hydration
via
intravenous
administration
of
fluids.
Most
dogs
recover
from
canine
influenza
within
2-3
weeks.4
Currently
available
antiviral
drugs
are
approved
for use
in
humans
only and
little
is known
about
their
use,
efficacy
and
safety
in dogs.
Veterinarians
who use
approved
drugs in
a manner
that is
not in
accord
with
approved
label
directions
(e.g.,
use of
an
antiviral
drug
only
approved
for use
in
humans)
must
follow
the
federal
extralabel
drug use
regulations
of the
Animal
Medicinal
Drug Use
Clarification
Act (AMDUCA).
Morbidity
and
mortality
The
morbidity
rate
(the
number
of
exposed
animals
that
develop
disease)
associated
with
canine
influenza
is
estimated
at 80%.
Deaths
occur
mainly
in dogs
with the
severe
form of
disease;
the
mortality
rate is
thought
to be
1-5% or
slightly
higher.
Higher
case
fatality
rates
have
been
reported
in small
groups
of
greyhounds
that
developed
hemorrhagic
pneumonia
during
outbreaks.5
Prevention
and
control
In
veterinary,
boarding
and
shelter
facilities,
the
canine
influenza
virus
appears
to be
easily
killed
by
disinfectants
commonly
used in
these
facilities,
such as
quaternary
ammonium
compounds
(eg,
benzalkonium
chloride)
and
bleach
solutions.4
Protocols
should
be
established
for
thoroughly
cleaning
and
disinfecting
cages,
bowls
and
other
surfaces
between
uses.
The
virus
may
persist
in the
environment
for
approximately
2 days,
and be
viable
on hands
and
clothing
for up
to 24
hours
Employees
should
wash
their
hands
with
soap and
water:
before
and
after
handling
each dog
after
coming
into
contact
with
dogs'
saliva,
urine,
feces,
or blood
after
cleaning
cages
upon
arriving
at and
before
leaving
the
facility.
Isolation
protocols
should
be
rigorously
applied
for dogs
showing
clinical
signs of
respiratory
disease.
Sick or
exposed
dogs
should
be
isolated
for two
weeks.
Clothing,
equipment,
surfaces
and
hands
should
be
cleaned
and
disinfected
after
exposure
to dogs
showing
signs of
respiratory
disease.2
Dog
owners
whose
dogs are
coughing
or
exhibiting
other
signs of
respiratory
disease
should
not
participate
in
activities
or bring
their
dogs to
facilities
where
other
dogs can
be
exposed
to the
virus.7
In May
2009,
the USDA
approved
the
licensure
of the
first
influenza
vaccine
for dogs
developed
by
Intervet/Schering
Plough
Animal
Health
Corporation.
The
canine
influenza
vaccine
contains
inactivated
whole
virus.8,9
The
vaccine
is
intended
as an
aid in
the
control
of
disease
associated
with CI
virus
infection.
Although
the
vaccine
may not
prevent
infection
altogether,
efficacy
trials
have
shown
that the
vaccination
may
significantly
reduce
the
severity
and
duration
of
clinical
illness,
including
the
incidence
and
severity
of
damage
to the
lungs.4
In
addition,
the
vaccine
reduces
the
amount
of virus
shed and
shortens
the
shedding
interval;
therefore,
vaccinated
dogs
that
become
infected
develop
less
severe
illness
and are
less
likely
to
spread
the
virus to
other
dogs.9
These
benefits
are
similar
to those
provided
by
influenza
vaccines
used in
other
species,
including
humans.
The
canine
influenza
vaccine
is a
"lifestyle"
vaccine,
and is
not
recommended
for
every
dog.4 In
general,
the
vaccine
is
intended
for the
protection
of dogs
at risk
for
exposure
to the
CI
virus,
which
include
those
that
either
participate
in
activities
with
many
other
dogs or
are
housed
in
communal
facilities,
particularly
where
the
virus is
prevalent.
Dogs
that may
benefit
from
canine
influenza
vaccination
include
those
that
receive
the
kennel
cough (Bordetella/parainfluenza)
vaccine,
because
the risk
groups
are
similar.5
Dog
owners
should
consult
with
their
veterinarian
to
determine
whether
their
dog's
lifestyle
includes
risks
for
exposure
to the
CI
virus,
and if
the
vaccine
is
appropriate
for
their
dog.6, 9
We would
like to
thank
Dr.
Cynda
Crawford
from the
University
of
Florida
College
of
Veterinary
Medicine
for her
contributions
to the
AVMA's
canine
influenza
resources.
Links to
more
information
about
canine
influenza
Control
of
Canine
Influenza
in Dogs:
Questions,
Answers
and
Interim
Guidelines
(AVMA)
Canine
Influenza:
Podcast
by Dr.
Cynda
Crawford
(AVMA)
Key
Facts
about
Canine
Influenza
(Centers
for
Disease
Control
and
Prevention)
Canine
Influenza:
Frequently
Asked
Questions
by Dog
Owners
(University
of
Florida
College
of
Veterinary
Medicine)
Canine
Influenza
Fact
Sheet
(Iowa
State
University)
Canine
Influenza
(University
of
California-Davis
Shelter
Medicine
Program)
Canine
Influenza
Virus:
Detection,
Sampling
and
Statistics
(Cornell
University
Veterinary
Diagnostic
Laboratory)
References
Meyer M.
UF
veterinary
researchers
discover
a new
disease
in dogs.
Explore:
Research
at the
University
of
Florida;
2006:11.
Available
at:
http://www.research.ufl.edu/publication
...
tory3.html.
Accessed
on
August
19,
2009.
Crawford
C.
Canine
influenza:
Frequently
asked
questions
from dog
owners.
University
of
Florida;
2009.
Available
at:
http://www.vetmed.ufl.edu/college/pr/do
...
rs_001.pdf
.
Accessed
on
August
19,
2009.
Cornell
University:
College
of
Veterinary
Medicine.
Emerging
issues -
Canine
influenza:
Test
summary
for
canine
influenza
virus in
dogs not
affiliated
with
greyhound
racetracks
Animal
Health
Diagnostic
Center.
Available
at:
http://www.diaglab.vet.cornell.edu/issues/civ-stat.asp.
Accessed
on
August
19,
2009.
Crawford
C.
Canine
influenza:
Frequently
asked
questions
from
veterinarians.
University
of
Florida;
2009.
Available
at:
http://www.vetmed.ufl.edu/college/pr/do
...
ns_000.pdf
.
Accessed
on
September
3, 2009.
Iowa
State
University.
Canine
Influenza
2009.
Available
at:
http://www.cfsph.iastate.edu/Factsheets
...
luenza.pdf.
Accessed
on
August
19,
2009.
Control
of
canine
influenza:
Questions,
answers,
and
interim
guidelines.
American
Veterinary
Medical
Association;
2005.
Available
at:
http://www.avma.org/public_health/influ
...
elines.asp.
Accessed
on
August
19,
2009.
Cornell
University:
College
of
Veterinary
Medicine.
Emerging
issues -
Canine
influenza
virus.
Animal
Health
Diagnostic
Center;
2006.Available
at:
http://www.diaglab.vet.cornell.edu/issues/civ.asp
.
Accessed
on
August
19,
2009.
United
States
Department
of
Agriculture.
Animal
and
Plant
Inspection
Service.
Veterinary
Services:
Center
for
Veterinary
Biologics.
Center
for
Veterinary
Biologics
Notice
No.
09-13.
Issuance
of
Licenses.
2009.
Available
at:
http://www.aphis.usda.gov/animal_health
...
_09_13.pdf.
Accessed
on
August
19,
2009.
Cole, L.
McNally,
A. APHIS
issues
conditional
license
for
canine
influenza
virus
vaccine.
United
States
Department
of
Agriculture.
Animal
and
Plant
Inspection
Service;
2009.
Available
at:
http://www.aphis.usda.gov/newsroom/cont
...
vacc.shtml.
Accessed
on
August
19,
2009.